Neptune Wellness Solutions Logo
CA64079L1058
A2N6DW
NEPT

Neptune Wellness Solutions

Loading quotes...

Forecast

Buy
  1
Hold
  0
Sell
  0

  • Neptune sets price for secondary offering at $27.50 per share

    Neptune set the price for a secondary offering of 9,841,395 Class A shares at $27.50 per share; the shares are being sold by selling shareholders and the company will not receive any proceeds. Neptune intends to repurchase and retire 984,140 shares from the underwriters at $26.40 per share; closing is expected on Friday and is subject to customary conditions and the successful completion of the offering. The underwriters have been granted a 30-day option to purchase up to 1,476,209 additional shares at the offering price. Morgan Stanley is lead left bookrunner; the S-1 was declared effective by the SEC on May 13, 2026. The stock is trading at $27.94, market capitalization is $3.95 billion, analysts expect a return to profitability, and InvestingPro currently views the stock as overvalued. » More on de.investing.com


  • Neptune announces secondary placement of 8.36 million shares by selling shareholders

    Certain selling shareholders of Neptune intend to publicly place 8,355,615 class A common shares; the syndicate banks have a 30-day option on up to 1,253,342 additional shares. Neptune will also repurchase 835,561 shares from the syndicate banks at the same price and cancel them, subject to customary closing conditions and a successful offering. Morgan Stanley is lead left bookrunner, J.P. Morgan and Goldman Sachs are active bookrunners; a Form S-1 registration statement has been filed with the SEC but is not yet effective. The announcement follows a 22% rise in the stock last week; Neptune is due to report results in two days, and analysts expect a return to profitability. » More on de.investing.com


  • Neptune targets IPO in New York after strong growth and high margin

    Flood insurer Neptune has filed for an IPO in New York and plans to list under the ticker NP. The company, founded in 2018, reported $119.3m in revenue and $34.6m in net income in 2024, implying roughly a 29% margin; H1 2025 also showed further strong growth. The offering is being led by Morgan Stanley, J.P. Morgan and BofA Securities, with BMO Capital Markets, Goldman Sachs and Evercore ISI as additional syndicate banks. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics
In 2008, Neptune Wellness Solutions has already paid €0.19 in dividends. The last payout was in August 2008.

Financials

In the last year, Neptune Wellness Solutions had revenue of €48.4M and net profit of -€75.17M
(EUR) 2023
YoY
Revenue 48.4M 9.82%
Gross profit -4.51M 58.63%
Net profit -75.17M 11.21%
EBITDA -58M 19.61%

Fundamentals

Metric Value
Market capitalization
€735.67K
Number of shares
4.29M
52-week high/low
€0.17 - €0.17
Dividends No
Beta
2.19
P/E ratio
-2.79
PEG ratio
-0.02
P/B ratio
4.94
P/S ratio
0.00

Company profile

Neptune Wellness Solutions Inc. ist als integriertes Gesundheits- und Wellnessunternehmen tätig. Es baut ein Portfolio von Lifestyle-Marken und Konsumgütern unter den Marken Biodroga Neutraceuticals, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh und NurturMe auf. Das Unternehmen bietet schlüsselfertige Produktentwicklungs- und Lieferkettenlösungen für Geschäftskunden in verschiedenen Gesundheits- und Wellnessbereichen an, wie z. B. legales Cannabis und Hanf, Nahrungsergänzungsmittel und verpackte Konsumgüter mit weißem Etikett. Das Unternehmen befasst sich auch mit der Extraktion, Reinigung, Formulierung und Herstellung von Gesundheits- und Wellnessprodukten wie Omega-3- und Hanfprodukten in verschiedenen Darreichungsformen wie Softgels, Flüssigkeiten, Kapseln, Vape-Pens, Sprays, topischen Produkten, Beuteln, Tinkturen, Konzentraten, Esswaren und Getränken sowie Handdesinfektionsmitteln, berührungslosen Thermometern und Handschuhen. Darüber hinaus bietet das Unternehmen Maxsimil an, eine Technologie zur Verabreichung von Omega-3-Fettsäuren, bei der Enzyme verwendet werden, die das natürliche menschliche Verdauungssystem nachahmen, um Omega-3-Fettsäuren vorzuverdauen. Es hat eine Kooperationsvereinbarung mit International Flavors & Fragrances Inc. zur gemeinsamen Entwicklung von aus Hanf gewonnenen CBD-Produkten für den Masseneinzelhandel sowie den Gesundheits- und Wellnessmarkt. Das Unternehmen wurde 1998 gegründet und hat seinen Hauptsitz in Laval, Kanada.

Name
Neptune Wellness Solutions
CEO
Lisa H. Gainsborg CPA
Headquarters Laval, qc
Canada
Website
Sector
Materials
Industry
Chemicals
IPO
08/13/2007
Employees 50

Ticker symbols

Exchange Symbol
NASDAQ
NEPT

Discover assets

Shareholders of Neptune Wellness Solutions also invest in the following assets

🍪

Parqet  uses cookies. Learn more